SMTL ID : 7lgs.2 (3 other biounits)

Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

monomer

Ligands

4 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.1: 2 residues within 4Å: Chain A: K.132 Ligands: EDO.2 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.132, A:K.132 EDO.2: 3 residues within 4Å: Chain A: K.132, S.278 Ligands: EDO.1 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:K.132, A:K.132, A:S.278 Water bridges: A:R.282 EDO.4: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) EDO.6: 4 residues within 4Å: Chain A: N.125, V.128, Q.129, K.132 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:K.132 Water bridges: A:K.132

1 x Q6K: ~{N}-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]propanamide(Covalent)

Q6K.3: 14 residues within 4Å: Chain A: L.24, G.25, V.32, A.49, Q.100, L.101, M.102, P.103, G.105, C.106, D.109, R.150, L.153, D.164 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:L.24, A:V.32, A:V.32, A:V.32, A:A.49, A:L.153 Hydrogen bonds: A:M.102, A:M.102, A:C.106, A:D.109 Salt bridges: A:D.109

1 x CIT: CITRIC ACID(Non-functional Binders)

CIT.5: 6 residues within 4Å: Chain A: N.80, P.81, R.85, K.155, H.159, K.161 8 PLIP interactions: 8 interactions with chain A Hydrogen bonds: A:K.161 Water bridges: A:H.159 Salt bridges: A:R.85, A:K.155, A:K.155, A:H.159, A:K.161, A:K.161

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gonzalvez, F. et al., Mobocertinib (TAK-788): A Targeted Inhibitor of EGFR Exon 20 Insertion Mutants in Non-Small Cell Lung Cancer. Cancer Discov (2021)

Release Date

2021-09-22

Peptides

Epidermal growth factor receptor: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Epidermal growth factor receptor

Related Entries With Identical Sequence